Key Market Indicators
Serbian pharmaceutical production is projected to reach approximately €6.5 million by 2028, up from €5.8 million in 2023. This represents an average annual growth rate of 1.6%. Since 2019, Serbia's pharmaceutical supply has seen an annual increase of 8.8%. In the 2023 rankings, Serbia held the 16th position, with Poland slightly ahead at €5.8 million. Italy, Spain, and Austria secured the 2nd, 3rd, and 4th positions respectively in this ranking.
